|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold and securities purchased under reverse repurchase agreements | ||||||||||||||||||||
| Securities available for sale, at fair value (amortized cost: $1,938,959-2026 $1,842,444-2025; allowance for credit losses (ACL): $0-2026; $0-2025) | ||||||||||||||||||||
| Securities held to maturity, net of ACL of $0 (fair value: $1,096,876-2026; $1,180,569-2025) | ||||||||||||||||||||
| Loans held for sale (LHFS) | ||||||||||||||||||||
| Loans held for investment (LHFI) | ||||||||||||||||||||
| Less ACL, LHFI | ||||||||||||||||||||
| Net LHFI | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Mortgage servicing rights (MSR) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Identifiable intangible assets, net | ||||||||||||||||||||
| Other real estate, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets of discontinued operations | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal funds purchased | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Subordinated notes | ||||||||||||||||||||
| Junior subordinated debt securities | ||||||||||||||||||||
| ACL on off-balance sheet credit exposures | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Liabilities of discontinued operations | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Authorized: 250,000,000 shares Issued and outstanding: 58,225,687 shares - 2026; 59,012,423 shares - 2025 | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss), net of tax | ||||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders' Equity | ||||||||||||||||||||
Loading...
